Occurrence of co-existing bla VIM-2 and bla NDM-1 in clinical isolates of Pseudomonas aeruginosa from India

Annals of Clinical Microbiology and Antimicrobials

Volumn 15, Issue 1, 2016, Pages

  Paul, Deepjyoti ^a   Dhar, Debadatta ^b   Maurya, Anand Prakash ^a   Mishra, Shweta ^c   Sharma, Gauri Dutt ^a   Chakravarty, Atanu ^b   Bhattacharjee, Amitabha ^a  

^a ASSAM UNIVERSITY   (India)

^b SILCHAR MEDICAL COLLEGE AND HOSPITAL   (India)

^c BANARAS HINDU UNIVERSITY   (India)

Author keywords

NDM 1; VIM 2; bla; Inc F type; Integron; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BLANDM 1 GEME; BLAVIM 2 GENE; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENE CASSETTE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC BACKGROUND; GENETIC STABILITY; HETEROZYGOTE; HUMAN; INDIA; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR DYNAMICS; NONHUMAN; PLASMID; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; REPLICON; SOUTHERN BLOTTING; WILD TYPE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PSEUDOMONAS INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; FEMALE; HUMANS; INDIA; INTEGRONS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84965032465     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/s12941-016-0146-0     Document Type: Article

References (20)

1. Patel G, Bonomo RA. "Stormy waters ahead": global emergence of carbapenemases. Front Microbiol. 2013;48:1-17.
2. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β-lactamase: a last frontier for β lactams? Lancet Infect Dis. 2011;11:381-93.
3. VIM-1 gene associated with different Tn402 variants, mercury transposons and conjugative plasmids in enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2010;54:320-7.
4. NDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India. Antimicrob Agents Chemother. 2009;53:5046-54.
5. Castanheira M, Bell JM, Turnidge JD, Mathai D, Jones RN. Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2,-5,-6, and -11 and the newly characterized VIM-18). Antimicrob Agents Chemother. 2009;53:1225-7.
6. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson D, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:597-602.
7. th edn. Edinburgh: Churchill, Livingstone; 1996.
8. VIM-2 gene cassettes. J Antimicrob Chemother. 2002;49:837-40.
9. Lee S, Park YJ, Kim M, Lee HK, Han K, Kang CS. Prevalence of Ambler class A and D β- lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother. 2005;56:122-7.
10. Koeleman JGM, Stoof J, Der Bijl MWV, Vandenbroucke-grauls CMJE, Savelkoul PHM. Identification of Epidemic Strains of Acinetobacter baumannii by Integrase Gene PCR. J Clin Microbiol. 2001;39:8-13.
11. NDM-1 is a chimera likely constructed in Acinetobacter baumannii. Antimicrob Agents Chemother. 2012;56:2773.
12. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219-28.
13. Clinical Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. 2013; M100-S23. CLSI, Wayne.
14. Locke JB, Rahawi S, LaMarre J, Mankin LS, Shawa KJ. Genetic Environment and Stability of cfr in Methicillin-resistant Staphylococcus aureus CM05. Antimicrob Agents and Chemother. 2012;56:332-40.
15. Tato M, Coque TM, Ruiz-Garbajosa P, Pintado V, Cobo J, Sader HS, Jones RN, Baquero F. Complex clonal and plasmid epidemiology in the first outbreak of enterobacteriaceae infection involving VIM-1 metallo-β-lactamase in Spain: towards endemicity? Clin Infect Dis. 2007;45:1171-8.
16. /conserved sequence. Antimicrob Agents and Chemother. 2007;51:2636-8.
17. Jovcic B, Lepsanovic Z, Suljagic V, Rackov G, Begovic J, Topisirovic L, Kojic M. Emergence of NDM-1 metallo-β-lactamase in Pseudomonas aeruginosa clinical isolates from Servia. Antimicrob Agents Chemother. 2011;55:3929-31.
18. NDM-1 gene in a novel genetic context. Antimicrob Agents Chemother. 2013;57:3405-7.
19. Mishra S, Upadhyay S, Sen MR, Maurya AP, Choudhury D, Bhattacharjee A. Genetic Acquisition of NDM Gene Offers Sustainability among Clinical Isolates of Pseudomonas aeruginosa in Clinical Settings. PLoS ONE. 2015;10(1):e0116611. doi: 10.1371/journal.pone.0116611.
20. NDM-1 in Clinical Isolates of Pseudomonas aeruginosa Associated with Hospital Infections from India. PLoS ONE. 2015;10(12):e0145823. doi: 10.1371/journal.pone.0145823.